コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 skin syndrome (PSS), an autosomal recessive skin disorder.
2 ncies and in psoriasis, a hyperproliferative skin disorder.
3 isoform 1), causes Hailey-Hailey disease, a skin disorder.
4 s for this inherited, currently intractable, skin disorder.
5 a paradigm for treating a localized dominant skin disorder.
6 opic dermatitis (AD), a chronic inflammatory skin disorder.
7 rstanding of the pathobiology of this common skin disorder.
8 D) is a highly pruritic chronic inflammatory skin disorder.
9 Atopic dermatitis (AD) is a common skin disorder.
10 the mechanisms of skin aging and age-related skin disorders.
11 offer a potential tool for the treatment of skin disorders.
12 r loss, wound healing and other degenerative skin disorders.
13 therapeutic strategies against aging-related skin disorders.
14 eveloping treatments for hair loss and other skin disorders.
15 ial asthma, inflammatory bowel diseases, and skin disorders.
16 inflammation, and dominant negative genetic skin disorders.
17 understanding, particularly for inflammatory skin disorders.
18 sk of congenital malformations, alopecia, or skin disorders.
19 egrity may underlie or contribute to various skin disorders.
20 ytokine that has pathogenic roles in various skin disorders.
21 ess observed in PC and related keratin-based skin disorders.
22 s common to wound repair and many neoplastic skin disorders.
23 of a novel therapeutic approach for treating skin disorders.
24 icta, a close relative implicated in similar skin disorders.
25 sis and lamellar ichthyosis, two devastating skin disorders.
26 ectors, may be effective agents for treating skin disorders.
27 for wounds, hair loss and other degenerative skin disorders.
28 el targets for the treatment of inflammatory skin disorders.
29 n may positively affect the course of common skin disorders.
30 icine in the development of formulations for skin disorders.
31 erapeutic benefit in some human inflammatory skin disorders.
32 ired for the development of Th1 inflammatory skin disorders.
33 novel therapy against constantly increasing skin disorders.
34 s to the pathogenesis of psoriasis and other skin disorders.
35 r a variety of cutaneous neoplasms and other skin disorders.
36 es various pathologies including cancers and skin disorders.
37 reatment of psoriasis and other inflammatory skin disorders.
38 regimens for the management of inflammatory skin disorders.
39 dermal gene expression in hyperproliferative skin disorders.
40 al approach to the treatment of inflammatory skin disorders.
41 treatment of skin cancer and possibly other skin disorders.
42 se compounds as pharmaceutics for cancer and skin disorders.
43 rovided valuable insights into human genetic skin disorders.
44 unexplained gastrointestinal, neurologic, or skin disorders.
45 y activity in a number of chronic autoimmune skin disorders.
46 utic implications for the treatment of other skin disorders.
47 es for the topical treatment of inflammatory skin disorders.
48 is and other hyperproliferative inflammatory skin disorders.
49 on by TREX1 may contribute to photosensitive skin disorders.
50 gy metabolism have been reported in multiple skin disorders.
51 idermal differentiation characterize various skin disorders.
52 to predict novel treatments for a number of skin disorders.
53 d its deficiency causes immunodeficiency and skin disorders.
54 en exploring NRF2 as a therapeutic target in skin disorders.
55 , a validated quality of life instrument for skin disorders.
56 involvement of EMILINs in fibrillin-related skin disorders.
57 a role in inflammation, pain sensation, and skin disorders.
58 nsdermal drug carriers to treat a variety of skin disorders.
59 ytokine tightly associated with inflammatory skin disorders.
60 reating neutrophilia-associated inflammatory skin disorders.
61 f homeostasis, skin injury, and inflammatory skin disorders.
62 spiratory (15%), gastrointestinal (12%), and skin disorders (10%); polyneuropathy was infrequent (1%)
63 rash (88.6%), dry skin (34.3%), asthenia and skin disorders (31.4%), mucositis/stomatitis (25.7%), fe
65 is is a highly pruritic chronic inflammatory skin disorder affecting 10-20% of children worldwide.
66 y skin diseases, such as psoriasis, a common skin disorder affecting approximately 2% of the US popul
69 23; 95% CI, 1.45-3.46; P < .001) and bullous skin disorders (AHR, 4.88; 95% CI, 2.47-9.66; P < .001)
71 c dermatitis is the most common inflammatory skin disorder and characterized by abnormalities in both
73 , plakophilin 1 has been linked to a genetic skin disorder and shown to play important roles in desmo
76 nce of Staphylococcus (S.) aureus-associated skin disorders and atopy was reviewed, as these are the
78 idermal adhesion is a hallmark of blistering skin disorders and chronic wounds, implicating integrins
79 pproach to understanding the pathogenesis of skin disorders and for developing therapeutic strategies
82 s the diagnosis and treatment of sun-related skin disorders and recommendations for reducing photodam
89 ct dermatitis (ACD), a pruritic inflammatory skin disorder, and both mast cell number and PAMP1-20 co
92 ople were for trauma, respiratory disorders, skin disorders, and infectious diseases (excluding the a
93 iated with barrier impairment and consequent skin disorders, and it is therefore important to monitor
101 que-type psoriasis is a chronic inflammatory skin disorder associated with chemoattractants driving n
102 s autosomal recessively inherited blistering skin disorder associated with fragility at the dermal-ep
103 ic dermatitis (AD) is a chronic inflammatory skin disorder associated with heterogenous presentation
104 s commonly used to treat psoriasis, a common skin disorder associated with rapid proliferation of cel
106 a chronic, inflammatory, intensely pruritic skin disorder associated with significant patient burden
107 nts could be beneficial for the treatment of skin disorders associated with hyperproliferation and/or
108 However, the LTR/IFD can also be seen in skin disorders associated with systemic illnesses (lupus
109 onic spontaneous urticaria (CSU) is a common skin disorder, but its clinical course reported so far i
111 common immune-mediated chronic inflammatory skin disorder, but the mechanisms of pathogenesis are st
112 observed in patients with various inherited skin disorders, but not in connexin-related disease.
115 ly available microarray data from a range of skin disorders can elucidate disease pathways, generate
116 phic epidermolysis bullosa is a rare genetic skin disorder caused by COL7A1 sequence variations that
118 of harlequin ichthyosis (HI), a devastating skin disorder caused by loss-of-function mutations in th
119 olysis bullosa (RDEB) is a complex inherited skin disorder caused by loss-of-function mutations in th
120 olysis bullosa simplex (EBS) is an inherited skin disorder caused by mutations in keratins K5 (kerati
121 is bullosa (RDEB) is an inherited blistering skin disorder caused by mutations in the COL7A1 gene-enc
123 cause of ichthyosis vulgaris (IV), a common skin disorder characterised by dry skin, palmar hyperlin
124 Atopic dermatitis is a common inflammatory skin disorder characterised by recurrent eczematous lesi
125 pic dermatitis (AD) is a common inflammatory skin disorder characterized by a heterogeneous and fluct
126 -Hailey disease (HHD), an autosomal dominant skin disorder characterized by abnormal keratinocyte adh
127 underlie harlequin ichthyosis, a devastating skin disorder characterized by abnormal lamellar bodies
128 ARCI) is a heterogeneous group of hereditary skin disorder characterized by an aberrant cornification
129 ton syndrome is a severe autosomal recessive skin disorder characterized by congenital erythroderma,
130 ic dermatitis (AD) is a chronic inflammatory skin disorder characterized by defective skin barrier an
131 amellar ichthyosis is a congenital recessive skin disorder characterized by generalized scaling and h
134 disease is an autosomal dominantly inherited skin disorder characterized by loss of adhesion between
135 Darier disease (DD) is an autosomal-dominant skin disorder characterized by loss of adhesion between
136 se (DD) is an autosomal dominantly inherited skin disorder characterized by loss of adhesion between
138 erythema (KWE) is a rare autosomal-dominant skin disorder characterized by recurrent episodes of pal
139 us urticaria (CSU) is a common, debilitating skin disorder characterized by recurring episodes of rai
140 iley-Hailey disease is an autosomal dominant skin disorder characterized by suprabasal cell separatio
142 dermatitis, a chronic relapsing inflammatory skin disorder characterized by universal colonization wi
143 rier's disease (DD) is an autosomal dominant skin disorder characterized clinically by multiple kerat
144 , or acne inversa, is a chronic inflammatory skin disorder characterized clinically with acne-like le
145 ease (DD) is an inherited autosomal-dominant skin disorder characterized histologically by loss of ad
146 congenita (PC) is a rare autosomal dominant skin disorder characterized predominantly by nail dystro
147 ing could comprise a novel approach to treat skin disorders characterized by abnormalities in differe
148 ormalities in Ctip2 could therefore underlie skin disorders characterized by an aberrant epidermal pe
149 refers to a heterogeneous group of inherited skin disorders characterized by blister formation within
150 stular psoriasis indicates a group of severe skin disorders characterized by eruptions of neutrophil-
151 g was specific and was not observed in other skin disorders characterized by erythema and abnormal co
152 atin genes can cause a number of inheritable skin disorders characterized by intraepidermal blisterin
153 LIMK1 is lost in psoriatic lesions and other skin disorders characterized by lack of cell compaction
154 disease is an autosomal dominantly inherited skin disorder, characterized by loss of adhesion between
155 ies in adults and children, across different skin disorders, correlating blood and skin phenotypes an
156 ce offers therapeutic potential for treating skin disorders, delivery hurdles have hampered clinical
157 d that is associated with deafness but has a skin disorder distinct from the KID syndrome mutations.
160 nockout mice harboring mutations relevant to skin disorders, few organotypic mouse skin models are av
164 nvestigate the molecular basis of 3 pustular skin disorders: generalized pustular psoriasis (GPP), pa
166 id, and parathyroid function; weight change; skin disorders; hair disorders; and teratogenicity.
167 ery of new genetic determinants of inherited skin disorders has been instrumental to the understandin
168 The discovery of genetic causes of inherited skin disorders has been pivotal to the understanding of
170 st, integrative biological analysis of human skin disorders has revealed unexpected functions for ele
171 igation of genetic determinants of Mendelian skin disorders has substantially advanced understanding
173 dentified as the cause of the common genetic skin disorder ichthyosis vulgaris (IV), the most prevale
174 utations in the FLG gene underlie the common skin disorder ichthyosis vulgaris and are significant ri
177 nce their absence gives rise to a blistering skin disorder in neonatal epidermis, and hemorrhaging wi
179 Hidradenitis suppurativa (HS) is a common skin disorder in which excessive inflammation is believe
180 hyosis vulgaris (IV) is an inherited scaling skin disorder in which expression of profilaggrin is red
181 of desmo-plakin and also the first inherited skin disorder in which haploinsufficiency of a structura
186 ) is a heterogeneous group of rare inherited skin disorders in which defects in cell adhesion compone
187 such events are particularly evident in some skin disorders in which normal clones develop on a backg
188 at may result in the development of fibrotic skin disorders in which reduced fibrinolysis is a featur
190 skin mycobiome and is associated with common skin disorders including atopic eczema (AE)/dermatitis.
191 involved in the pathogenesis of a number of skin disorders including photosensitivity diseases and s
192 nt of several ayurvedic preparations against skin disorders including psoriasis and herpes, though no
193 of LXR as a potential therapeutic target for skin disorders including skin aging, psoriasis, and atop
197 isease Area Index (PDAI), Autoimmune Bullous Skin Disorder Intensity Score (ABSIS), and Pemphigus Vul
200 ase Area Index (PDAI) and Autoimmune Bullous Skin Disorder Intensity-Score (ABSIS) scores have been p
204 group of autosomal dominant human blistering skin disorders it was discovered that defects in the ker
205 lantar keratoderma, a rare dominant-negative skin disorder, its functional significance is poorly und
206 neated in the autosomal recessive blistering skin disorder, junctional epidermolysis bullosa, particu
209 s produce syndromic deafness associated with skin disorders, like the Keratitis-Ichthyosis-Deafness s
210 s and is a potential target for treatment of skin disorders linked to abnormal sebaceous gland functi
212 phenotype provides a model for inflammatory skin disorders, may have general relevance to polygenic
213 e most effective treatments for inflammatory skin disorders might concomitantly suppress the immune r
214 lammasome sensor NLRP1 cause two overlapping skin disorders: multiple self-healing palmoplantar carci
215 che (n = 87 [52.4%]), anemia (n = 83 [50%]), skin disorders (n = 81 [48.8%]), back pain (n = 54 [32.5
217 nant condition characterized by the furrowed skin disorder of cutis gyrata, acanthosis nigricans, cra
219 asis (OMIM 177900) is a chronic inflammatory skin disorder of unknown pathogenesis affecting approxim
221 c epidermolysis bullosa (RDEB), a blistering skin disorder often accompanied by epidermal cancers.
223 ir loss, or alopecia, may occur as a primary skin disorder or because of an underlying health problem
225 mutation responsible for the rare monogenic skin disorder pachyonychia congenita (PC), we demonstrat
231 human p34, which is mutated in the inherited skin disorder punctate palmoplantar keratoderma type I.
232 atin genes as the cause of several inherited skin disorders raised the possibility that molecular-bas
233 rited human diseases, such as the blistering skin disorder recessive dystrophic epidermolysis bullosa
234 Current therapeutic strategies for genetic skin disorders rely on the complex process of grafting g
236 l reflux disease and blistering/desquamating skin disorder respectively in female duplication carrier
238 suggested that a number of different LTR/IFD skin disorders share a common inflammatory signaling pat
239 rmatitis (nACD) remains a major occupational skin disorder, significantly impacting the quality of li
241 ance of this finding in mediating androgenic skin disorders such as acne, hirsutism, or androgenetic
243 n of TLR2 was not seen in other inflammatory skin disorders such as atopic dermatitis or psoriasis.
248 and its function in modulating the course of skin disorders, such as AD, might result in novel therap
251 and cause syndromic deafness associated with skin disorders, such as keratitis-ichthyosis-deafness sy
253 tis (AD) is a chronic relapsing inflammatory skin disorder that affects approximately 15% of children
256 sive macular hypomelanosis (PMH) is a common skin disorder that causes hypopigmentation in a variety
257 genic systemic fibrosis (NSF) is a fibrosing skin disorder that develops in patients with kidney fail
258 e affected transgenic mice manifested with a skin disorder that fulfilled the clinical diagnostic cri
259 rpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity
260 rpetiformis (DH) is an autoimmune blistering skin disorder that is associated with intestinal gluten
261 lantar keratoderma) is an autosomal dominant skin disorder that is associated with the early onset of
262 splasia verruciformis (EV) is a rare genetic skin disorder that is characterized by the development o
265 D) is a highly prevalent, itchy inflammatory skin disorder that is thought to arise from a combinatio
266 ic dermatitis (AD) is a chronic inflammatory skin disorder that lacks ideal long-term treatment optio
267 ontaneous urticaria (CSU) is an inflammatory skin disorder that manifests with itchy wheals, angioede
270 s in several different benign and neoplastic skin disorders that are characterized by a prominent ang
271 ine model of hyperproliferative inflammatory skin disorders that is induced by transfer of minor hist
272 Although psoriasis is a hyperproliferative skin disorder, the possible role of amino acid transport
273 overy about the mutations underlying genetic skin disorders, there have been few therapeutic advances
274 orm the clinical management and treatment of skin disorders through diagnostic tests to stratify pati
278 CD1d in normal skin, psoriasis, and related skin disorders, using a panel of CD1d-specific mAbs.
287 rom normal human skin and hyperproliferative skin disorders were examined by immunohistochemistry and
288 Rosacea is a common chronic inflammatory skin disorder where upregulation of matrix metalloprotei
289 Atopic dermatitis (AD) is a common chronic skin disorder, which may persist into adulthood; however
290 gs in normal human skin and in parakeratotic skin disorders, which exhibit nuclear staining of granul
291 0 group, and 11/25 in the placebo group) and skin disorders, which were seen in 50/120 patients (26/6
292 r keratosis (NPPK) is an autosomal recessive skin disorder with a high, unmet medical need that is ca
293 ermatitis is a complex, chronic inflammatory skin disorder with a profound symptom burden, and substa
295 r type 6 (PTPN6) in a mouse that developed a skin disorder with clinical and histopathological featur
296 f Siemens (IBS) is a rare autosomal dominant skin disorder with clinical features similar to epidermo
300 in regeneration and the treatment of various skin disorders, yet research were rarely investigated ab